•Company has established best practices in protection and hygiene, to combat COVID-19
San José, May 04, 2020. ICU Medical, Inc., a world leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, reported that in the past few weeks, it has recruited additional staff due to an increased demand for medical devices produced in Costa Rica, to supply needs around the world.
In addition, the company announced that it will donate US $20,000 to Costa Rican authorities, to aid in the COVID-19 emergency response.
ICU Medical reaffirmed that it currently follows best practices for the prevention and protection of its employees, in accordance with instructions from the Costa Rican Ministry of Health and global corporate protocols.
Isaías González, General Director of the ICU Medical Plant in Costa Rica, stated, “We have made offers for 200 new positions in recent weeks, to push forward with the manufacture of essential medical products during the COVID-19 emergency. Our new employees have already been integrated into plant operations and are now working in accordance with the health and safety blueprint provided by the Ministry of Health.”
The protocols established at the Costa Rican plant are noteworthy in their guarantee of best practices in hygiene, health, environmental, and industrial safety for its employees, contractors, suppliers, and visitors.
The company’s commitment is evident in its strengthening of its Occupational Health Clinic; hiring additional health professionals and dedicating new spaces to health services and exams; the timely management of symptoms and health programs directly related to COVID-19; voluntary isolation of and company remuneration for vulnerable staff with a viral link; social distancing in the cafeteria, on transportation services, and in all common areas; a bonus or economic incentive to help families; work from home, whenever possible; entrance controls, including taking body temperatures upon entering the building; and sanitization of all areas.
Isaias Gonzalez, General Director of Operations, concluded that successful results for the administration of this pandemic will lie in mechanisms of prompt action from management, communication strategy and, above all, the behavior of employees and contractors, including their adherence with established guidelines.
In January, ICU celebrated its 20th anniversary in Costa Rica and announced an investment of US $13 million in its local plant. The investment, which was made at the La Aurora de Heredia location, included a new infusion pump manufacturing line and a state-of-the-art sterilization plant. Currently, the company has 2,400 employees in Costa Rica.
About ICU Medical
ICU Medical, Inc. (Nasdaq: ICUI) is one of the world's leading infusion therapy companies with global operations and a broad portfolio of products including IV smart pumps, kits, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, and cardiac monitoring systems, as well as safety and pain management software designed to help meet clinical, safety and workflow goals.
Additionally, the company manufactures automated pharmacy compound systems with workflow technology, closed-system transfer devices for hazardous medications, and cardiac monitoring systems to optimize patient fluid levels.
ICU Medical is based out of San Clemente, California. On February 3, 2017, ICU Medical finalized the acquisition of the Hospira Infusion Systems business from Pfizer Inc. For more information on ICU Medical, Inc. visit www.icumed.com